U.S. Urology Supplements Market - By Type, By Application, By Formulation, By Distribution Channel - Forecast, 2026-2035

U.S. Urology Supplements Market Size

The U.S. urology supplements market was valued at USD 843.4 million in 2025. The market is expected to reach from USD 893 million in 2026 to USD 1.6 billion in 2035, growing at a CAGR of 6.5% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by the increasing urinary disorders, an aging population, rising preventive health awareness, growing access to e-commerce platform, and advancements in clinically-backed natural urology formulation.

The U.S. urology supplements market supports consumer health by offering targeted formulations that promote urinary tract balance, prostate wellness, and kidney function through clinically backed vitamins, minerals, botanicals, and functional food. Growth is driven by rising UTI prevalence, expanding prostate cancer diagnostics in aging men, and increasing consumer preference for natural, preventive, and science-supported solutions.
 

Leading players such as dsm-firmenich, Zahler, Better Being Co., Nestlé, and Amway strengthen their presence through innovative ingredient technologies, diversified product lines, and strong multichannel distribution across retail, e-commerce, and practitioner networks. These companies leverage formulation expertise, brand credibility, and strategic partnerships to deliver high-quality, research-driven urology supplements that meet evolving consumer expectations. Their continued advancements support improved urinary health outcomes while reinforcing leadership in the fast-growing U.S. nutraceutical sector.
 

The market has increased from USD 706.5 million in 2022 and reached USD 797.6 million in 2024, with the historic growth rate of 7%. The U.S. urology supplements market is experiencing strong growth driven by a combination of demographic, clinical, and behavioral factors that continue to expand product demand. One of the primary drivers is the rising prevalence of urinary tract infections (UTIs), kidney health issues, and prostate-related conditions, which are becoming increasingly common across both younger and older populations. An aging demographic further accelerates market expansion, as men above 50 face higher risks of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms, leading to increased reliance on dietary supplements for symptom management and preventive care.
 

Growing consumer awareness of natural and non-prescription approaches to urinary wellness also boosts market uptake. Patients and health-conscious individuals are actively shifting toward evidence-based botanical extracts, probiotics, cranberry formulations, D-mannose, antioxidants, and mineral blends as safer, long-term solutions compared to conventional pharmaceuticals. This trend is reinforced by rising trust in clinical research supporting natural ingredients for urinary and prostate health.

E-commerce growth remains a powerful driver as well, offering convenience, variety, subscription models, and direct-to-consumer brands that enhance product accessibility nationwide. Digital health platforms and personalized nutrition services are further encouraging tailored supplementation habits. Advancements in formulation technologies such as bioavailability enhancement, clean-label ingredients, and targeted delivery systems, also stimulate market expansion by improving product efficacy and consumer confidence. Collectively, these factors contribute to a strong and sustained demand for urology supplements across the U.S. market.
 

Urology supplements are dietary formulations designed to support urinary tract, kidney, and prostate health. They typically include vitamins, minerals, botanicals, antioxidants, probiotics, and functional compounds that help prevent infections, reduce inflammation, improve urinary flow, and maintain overall urinary system function for both men and women.
 

U.S. Urology Supplements Market Trends

The increasing prevalence of urological disorders in the population is the major force that fuels the growth in the market. The disorders include conditions such as UTIs, BPH, kidney stones, overactive bladder, and chronic prostatitis, which are becoming increasingly common across diverse demographic groups.
 

• Higher incidence among women due to anatomical susceptibility, combined with the growing proportion of older men experiencing prostate enlargement, continues to push demand for non-prescription, preventive, and maintenance-oriented solutions. Recurrent UTIs and lifestyle-related urinary complications linked to dehydration, sedentary habits, and poor dietary patterns further amplify market expansion as consumers seek natural, long-term management approaches.
   
• Technological advancements in supplement formulation significantly reinforce this demand. Innovations such as enhanced bioavailability technologies, controlled-release delivery systems, standardized botanical extracts with clinically proven efficacy, and precision-blended probiotic strains improve therapeutic outcomes and consumer confidence.
   
• Companies are increasingly integrating evidence-backed ingredients such as cranberry PACs, D-mannose, saw palmetto, beta-sitosterol, pumpkin seed extract, and antioxidants into high-performance formulas. The emergence of clean-label, vegan, and allergen-free products also aligns with evolving consumer preferences and regulatory trends, making technologically advanced formulations a strong competitive differentiator.
   
• Macro-economic factors further contribute to the growth trajectory. The expanding aging population, rising healthcare expenditure, and increasing awareness of preventive health practices create a favorable environment for supplement adoption. Widespread insurance constraints and high costs associated with prescription medications encourage consumers to choose affordable, over-the-counter nutritional solutions for urinary wellness. Additionally, the shift toward digital purchasing behaviors and the maturation of the U.S. e-commerce ecosystem support broader market reach.
   
• At the micro-economic level, greater product availability, competitive pricing strategies, retail pharmacy expansion, targeted marketing, and influencer-driven consumer education reinforce demand. Stronger practitioner recommendations from urologists, gynecologists, and integrative health professionals also enhance credibility and adoption.
   

U.S. Urology Supplements Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on the type, the U.S. urology supplements market is bifurcated into multi ingredient and single ingredient. The multi ingredient segment has asserted its dominance in the market by securing a significant market share of 69.7% in 2025, driven by an upsurge in demand for comprehensive formulations addressing a multiple urological conditions, enhanced efficacy, convenience, and growing consumer preference for combination supplements. The segment is expected to exceed USD 1.1 billion by 2035, growing at a CAGR of 6.7% during the forecast period.
 

On the other hand, the single ingredient segment is expected to grow with a CAGR of 6.1%. The increased focus on targeted therapy, safety, ease of dosage, personalized supplementation, and consumer preference for specific, well-researched ingredients.
 

• The multi ingredient segment is experiencing strong growth due to its ability to address multiple urological conditions simultaneously. These supplements often combine vitamins, minerals, herbal extracts, and amino acids, which provide synergistic benefits, enhancing overall efficacy and patient compliance.
   
• With rising prevalence of benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), kidney-related disorders, and other urological conditions, consumers are increasingly seeking comprehensive solutions rather than single-target products. Multi ingredient formulations are particularly appealing to aging populations, as they support prostate health, urinary tract function, and kidney health in one supplement, reducing the need for multiple individual products.
   
• Technological advancements in extraction, formulation, and bioavailability enhancement have further improved the efficacy of multi ingredient supplements, making them more effective and clinically reliable. Marketing strategies emphasizing holistic wellness, combined with an increase in health-conscious consumers, also drive adoption.
   
• On the economic front, higher disposable incomes and growing awareness of preventive healthcare contribute to the segment’s growth. Additionally, the segment benefits from strong e-commerce and retail penetration, making these products easily accessible.
   
• The single ingredient segment held a revenue of USD 255.4 million in 2025, with projections indicating a steady expansion at 6.1% CAGR from 2026 to 2035.
   
• The segment is growing steadily, driven by increasing consumer preference for targeted therapies and transparency in supplement composition. Single-ingredient supplements, often featuring saw palmetto, beta-sitosterol, cranberry extract, or other clinically recognized compounds, are favored by consumers who want specific, evidence-backed interventions for conditions such as BPH, urinary tract infections, and kidney health.
  
   
• These products offer a clear understanding of dosage and efficacy, appealing to both healthcare professionals and informed consumers seeking predictable outcomes.
   
• Technological advancements in extraction and formulation have enhanced the purity, potency, and bioavailability of single-ingredient supplements, improving their therapeutic effectiveness.
  
  Additionally, single-ingredient supplements are often more affordable than multi ingredient formulations, making them attractive to price-sensitive consumers while still addressing key urological health concerns.
   
• Regulatory clarity and standardized quality control measures have increased consumer confidence in single-ingredient products. Marketing strategies emphasizing clinical evidence, natural sourcing, and minimal additives have further supported adoption.
   

Based on application, the U.S. urology supplements market is classified into urinary tract infections, prostate health, kidney health and bladder health. The urinary tract infections segment dominated the market with a revenue share of 66.2% in 2025 and is expected to reach USD 1.1 billion within the forecast period.
 

• The segment leads the market because of the high prevalence of UTIs, especially in women and older adults, and also in patients with diabetes or weakened immunity. Recurrences of UTIs create repeated demand for prevention and support supplements like extracts from cranberries, D-mannose, and probiotics, which are perceived to be safer than the continuous use of antibiotics.
   
• Rising awareness about antibiotic resistance has further encouraged consumers to seek natural or adjunctive therapies, fueling market growth. Additionally, advancements in nutraceutical formulations, including concentrated cranberry capsules and blends targeting urinary health, enhance efficacy and convenience, boosting consumer adoption.
   
• The increasing number of healthcare campaigns educating patients about UTI prevention, coupled with the ease of over-the-counter availability of supplements, also contributes to higher market penetration.
   
• The prostate health segment held a revenue of USD 163.7 million in 2025, with projections indicating a steady expansion at 6.4% CAGR from 2026 to 2035.
   
• The prostate health segment is driven by the increasing prevalence of benign prostatic hyperplasia (BPH) and other prostate-related disorders among men aged 50 and above in the U.S.
  Supplements containing saw palmetto, beta-sitosterol, and zinc have gained popularity due to their perceived ability to support urinary flow, reduce inflammation, and maintain prostate function.
   
• Growing awareness of prostate health and regular screening programs contribute to proactive preventive supplementation. Technological advancements in supplement formulations, such as bioavailability-enhanced capsules and combination nutraceuticals, improve effectiveness and consumer compliance.
   
• Additionally, rising lifestyle-related risk factors, including obesity and sedentary behavior, have heightened concerns regarding prostate disorders, further driving supplement demand.
• The kidney health segment held a revenue of USD 43.3 million in 2025, with projections indicating a steady expansion at 6.9% CAGR from 2026 to 2035.
   
• The kidney health segment is primarily driven by the rising prevalence of chronic kidney disease (CKD), hypertension, and diabetes, which are key risk factors for kidney dysfunction. Consumers are increasingly turning to supplements containing antioxidants, herbal extracts, and minerals like magnesium and potassium to support kidney function, reduce oxidative stress, and promote detoxification.
   
• Awareness campaigns about kidney health, early detection of kidney-related disorders, and guidance from healthcare providers encourage preventive supplementation.
   
• Technological innovations in nutraceuticals, including standardized herbal extracts and combination formulations, enhance therapeutic efficacy and appeal to health-conscious consumers.
   

Based on formulation, the U.S. urology supplements market is classified into capsules, softgels, tablets, powder and other formulations. The capsules segment dominated the market with a revenue share of 44.1% in 2025 and is expected to reach USD 689.7 million within the forecast period.
 

• The capsules segment leads in the U.S. market due to the convenience, precision in dosage, and stability of bioactive ingredients. Capsules are easy to swallow and, therefore, appealing for consumers who seek effective delivery of concentrated nutrients without any bitter taste associated with powders or tablets.
   
• The increasing prevalence of urological disorders such as benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and kidney health concerns drives demand for daily supplementation, with capsules offering reliable absorption and efficacy.
   
• Additionally, technological advancements in encapsulation, such as enteric coatings and slow-release formulations, enhance the bioavailability of active ingredients, supporting long-term therapeutic benefits.
   
• The softgels segment held a revenue of USD 166.2 million in 2025, with projections indicating a steady expansion at 7.3% CAGR from 2026 to 2035. The softgels segment is gaining traction due to superior solubility, faster absorption, and user-friendly administration. Softgels encapsulate oils and fat-soluble nutrients, such as saw palmetto and pumpkin seed oil, which are critical for prostate and urinary health, ensuring better bioavailability compared to traditional tablets.
   
• Consumer preference for convenient, easy-to-swallow formats that avoid the chalky texture of tablets or powders drives adoption. Technological innovations in softgel manufacturing, including liquid-filled and dual-layer capsules, improve nutrient stability, potency, and shelf life, enhancing therapeutic outcomes.
   
• The tablets segment held a revenue of USD 139.5 million in 2025, with projections indicating a steady expansion at 6.9% CAGR from 2026 to 2035. The tablets segment benefits from its affordability, ease of mass production, and long shelf life. Tablets can deliver precise doses of active ingredients like beta-sitosterol, cranberry extract, and other phytochemicals targeting urinary tract health, BPH, and kidney support.
   
• Their convenience in packaging and storage makes them accessible to a wide consumer base, particularly price-sensitive populations. Technological improvements, such as coated and chewable tablets, enhance taste masking, reduce gastrointestinal irritation, and improve bioavailability, increasing consumer adherence.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on distribution channel, the U.S. urology supplements market is bifurcated into brick & mortar and e-commerce. The brick & mortar segment dominated the market with a revenue share of 62.2% in 2025 and is expected to reach USD 524.2 million within the forecast period.
 

• There are various key reasons why the brick and mortar segment dominates the market. The strong presence of physical pharmacies, drugstores, and healthcare retail chains makes it very easy and convenient to access these places for end-consumers, especially older adults who prefer in-person consultations before buying supplements.
   
• Personalized guidance from pharmacists and healthcare professionals enhances consumer confidence, encouraging repeat purchases and adherence to recommended regimens.
   
• Many consumers trust established retail brands and associate physical stores with authenticity and product quality, reducing concerns over counterfeit or substandard supplements.
   
• The e-commerce segment held a revenue of USD 319.1 million in 2025, with projections indicating a steady expansion at 6.8% CAGR from 2026 to 2035.
   
• The e-commerce segment is growing rapidly, driven by increasing digital adoption and consumer preference for online shopping. Convenience is a primary driver, as consumers can order supplements anytime from home, eliminating the need to visit physical stores.
   

Looking for region specific data?

Download Free PDF

South Atlantic Urology Supplements Market

South Atlantic dominated the U.S. urology supplements market with the highest market share of 19.4% in 2025.

• The zone has a large population of aged individuals, particularly vulnerable to urological disorders such as benign prostatic hyperplasia, kidney health issues, and infections in the urinary tract, thereby increasing demand for supplements related to prostate and urinary health.
   
• Rising awareness about preventive healthcare and wellness among residents has boosted adoption of dietary and nutritional supplements. The presence of well-established healthcare infrastructure, including hospitals, specialty clinics, and pharmacies, facilitates easy accessibility to urology supplements across urban and semi-urban centers.
   
• Economic factors such as higher disposable income and steady employment rates further support consistent spending on health and wellness products. Additionally, the South Atlantic zone has a growing trend of e-commerce adoption, enabling residents to access a wider range of products and specialized formulations.
   

Pacific Central Urology Supplements Market

Pacific Central urology supplements market accounted for USD 109.8 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• There is a significant growth taking place within the zone, driven by a combination of demographic, healthcare, and economic factors. Among primary drivers is an increase in the prevalence of urological conditions among aging males in the zone, such as BPH, urinary tract infections, and renal disorders.
   
• Rising health awareness and preventive healthcare adoption encourage consumers to proactively include supplements in their daily routines. The presence of well-established retail chains and e-commerce platforms ensures easy accessibility to high-quality urology supplements, enhancing market penetration.
   
• Technological advancements in digital marketing, telehealth consultations, and app-based delivery services also facilitate informed purchasing decisions and convenience. Additionally, the zone benefits from a higher per capita disposable income and urbanized population, which supports premium supplement consumption.
   
• Healthcare professionals recommendations and increasing physician-patient interactions further drive consumer confidence and adherence to urology supplement regimens. Marketing initiatives, including social media campaigns, influencer endorsements, and promotional discounts, boost product visibility and demand.
   

U.S. Urology Supplements Market Share

The market operates as a fragmented, with DSM-Firmenich, Zahler, Better Being Co., Nestlé, and Amway collectively accounting for 19.4% of the market share. This competitive structure emphasizes product efficacy, safety, scientific validation, and consumer trust. Leading players maintain their positions through extensive product portfolios, including single ingredient, multi ingredient, softgels, capsules, tablets, and liquid formulations targeting prostate health, urinary tract support, kidney function, and urinary incontinence. Strong U.S.-based distribution networks across retail pharmacies, e-commerce platforms, and specialty health stores, alongside collaborations with healthcare providers and wellness practitioners, ensure timely availability and accessibility of supplements.
 

Market growth in the U.S. is driven by the rising prevalence of urological disorders such as benign prostatic hyperplasia (BPH), urinary tract infections, kidney issues, and prostate health concerns, increasing consumer demand for preventive and therapeutic supplements. Companies are investing in research and development to formulate bioactive, clinically validated ingredients, and high-bioavailability supplements that improve efficacy and consumer outcomes. Technological innovations in product formulation, personalized nutrition, and direct-to-consumer digital platforms are influencing purchasing decisions. Partnerships with healthcare professionals, wellness centers, and online platforms support wider adoption and awareness. Additionally, growing health consciousness, disposable income, and government-led preventive health initiatives are driving continuous product development and market expansion in the U.S. urology supplements sector.
 

U.S. Urology Supplements Market Companies

A few of the prominent players operating in the U.S. urology supplements industry include:

• Amway
• Better Being
• dsm-firmenich
• Garden of Life
• Himalaya Wellness Company
• Himalayan Organics
• Natrol
• Nestle
• NOW Foods
• Pure Encapsulations
• Solaray
• Szio+
• Theralogix
• Uqora
• Zahler
   
• dsm-firmenich

dsm-firmenich holds a market share of 6.4%. The company leverages advanced nutraceutical research to deliver clinically validated, high-bioavailability urology supplements. Its strengths include innovative ingredient formulations, science-backed efficacy, and global quality standards. Strong R&D capabilities, personalized nutrition solutions, and collaborations with healthcare providers enable DSM-Firmenich to enhance prostate, urinary tract, and kidney health, ensuring consumer trust and premium positioning.
 

• Zahler

Zahler focuses on premium, doctor-formulated urology supplements with natural, high-potency ingredients. Emphasizing purity, GMP-certified production, and targeted formulations for prostate and urinary health, Zahler builds strong consumer confidence. Direct-to-consumer distribution, transparency in sourcing, and evidence-backed product claims further distinguish Zahler as a trusted, high-quality brand in the U.S. urology supplements market.
 

U.S. Urology Supplements Industry News:

• In January 2025, Theralogix launched TheraCran Max, a cranberry and D-mannose urinary health supplement. NSF certified and made in the USA, it is available online through Theralogix’s official website and Amazon, providing consumers with a convenient, high-quality option to support urinary tract health while ensuring safety, efficacy, and reliability.
   
• In January 2024, Theralogix announced the launch of Mannose One, a D-mannose supplement containing a naturally occurring molecule that helps prevent bacterial adherence to the bladder lining and aids bacterial removal from the urinary tract. This product expands Theralogix’s urology supplement portfolio, offering consumers an effective, convenient solution to maintain urinary tract health.
   
• In August 2023, Modicare launched its Well range of dietary supplements in India, featuring multivitamins for men and women along with a cranberry + D-mannose formula targeting urinary health. Available through Modicare consultants, the range aims to provide accessible, convenient, and preventive solutions to support overall wellness and urinary tract health.
   
• In August 2021, Nestlé Health Science completed the acquisition of the core brands of The Bountiful Company, a leading supplier of vitamins, minerals, and herbal supplements. This strategic acquisition strengthened Nestlé Health Science’s health and nutrition portfolio, enhancing brand offerings and sales channels, and expanding its footprint in the U.S. dietary supplement market.
   

The U.S. urology supplements market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Multi ingredient
• Single ingredient

Market, By Application

• Urinary tract infections
• Prostate health
• Kidney health
• Bladder health

Market, By Formulation

• Capsules
• Softgels
• Tablets
• Powder
• Other formulations

Market, By Distribution Channel

• Brick & mortar
• E-commerce

The above information is provided for the following zones:

• East North Central
  • Illinois
  • Indiana
  • Michigan
  • Ohio
  • Wisconsin
• West South Central
  • Arkansas
  • Louisiana
  • Oklahoma
  • Texas
• South Atlantic
  • Delaware
  • Florida
  • Georgia
  • Maryland
  • North Carolina
  • South Carolina
  • Virginia
  • West Virginia
  • Washington, D.C.
• Northeast
  • Connecticut
  • Maine
  • Massachusetts
  • New Hampshire
  • Rhode Island
  • Vermont
  • New Jersey
  • New York
  • Pennsylvania
• East South Central
  • Alabama
  • Kentucky
  • Mississippi
  • Tennessee
• West North Centra
  • Iowa
  • Kansas
  • Minnesota
  • Missouri
  • Nebraska
  • North Dakota
  • South Dakota
• Pacific Central
  • Alaska
  • California
  • Hawaii
  • Oregon
  • Washington
• Mountain States
  • Arizona
  • Colorado
  • Utah
  • Nevada
  • New Mexico
  • Idaho
  • Montana
  • Wyoming